Peanut Allergy Treatment Palforzia® Indication Expanded by European Commission for Toddlers Stallergenes Greer, a biopharmaceutical company specializing in allergen immunotherapy (AIT), has announced that the European Commission (EC) has granted…
Cardiometabolic Innovator Verdiva Bio Launches with $410M+ Series A to Advance Therapies Verdiva Bio Limited (“Verdiva”), a new clinical-stage biopharmaceutical company, announced its official launch today, aiming to innovate therapies…
MaaT Pharma Announces Positive Phase 3 ARES Results for MaaT013 in Acute GvHD MaaT Pharma (EURONEXT: MAAT), a clinical-stage biotechnology company specializing in Microbiome Ecosystem Therapies™ (MET) to improve survival…
Vir Biotechnology Reports Positive Data in Ongoing Trials for VIR-5818 and VIR-5500 Vir Biotechnology, Inc. (Nasdaq: VIR) has presented encouraging preliminary Phase 1 data from two of its dual-masked T-cell…
Eye on 2025: Viridian Sets Priorities After Positive Phase 3 TED Data Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company committed to developing potential best-in-class treatments for serious and rare…
Cancer Treatment Localization: Boston Oncology Arabia & SPIMACO Partner in Saudi Arabia In a groundbreaking move to enhance cancer care in the Middle East, Boston Oncology Arabia and SPIMACO have…
Viz.ai Partners with 3 Pharma Companies, Expands to 60,000 Providers Viz.ai, a leader in AI-powered disease detection and care coordination, has announced major achievements in its mission to revolutionize healthcare…
Stoke Therapeutics Announces Phase 3 Study Plans for Zorevunersen in Dravet Syndrome Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company focused on RNA medicine to restore protein expression, announced today…
Announces REZZAYO® Approval in Spain for Invasive Candidiasis Treatment by Mundipharma Mundipharma announces today that Spain’s Ministry of Health has approved reimbursement for REZZAYO® (rezafungin acetate) as a treatment for…
Arcturus Begins Phase 2 Dosing for CF and OTC Deficiency Arcturus Therapeutics Holdings Inc., a pioneering company in mRNA medicine, announced that it has initiated Phase 2 multiple ascending dose…
FDA Grants Fast Track to Star Therapeutics for VGA039 in VWD Star Therapeutics, a clinical-stage biotechnology company focused on developing cutting-edge antibodies, has announced that the U.S. Food and Drug…
Appoints Giancarlo Benelli as Head of Europe at BeiGene BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company set to rebrand as BeOne Medicines Ltd., appoints Giancarlo…